Beloved Assam teacher Hamida Begum dies at 64 after long illness
Beloved Assam teacher Hamida Begum dies at 64 after long illness
Beloved Assam teacher Hamida Begum dies at 64 after long illness
Hamida Begum, a retired primary school teacher, passed away on February 25, 2023, at the age of 64. Known for her kindness and gentle nature, she had been battling kidney and heart diseases before her death. Her funeral prayer, or Janaza, was held in Nazira, Assam, the same evening at 10 pm.
Hamida Begum spent her career teaching at Luthuri Gaon Primary School. She retired only recently, in early 2023, after years of service in education. Colleagues and students often remembered her for her warmth and dedication.
She was married to the late Abdul Hasim Shah, a social worker who had passed away earlier. The couple had two sons, a daughter, and other close relatives who survive her.
Her health had been declining due to long-term treatment for kidney and heart conditions. Despite her illness, those who knew her recalled her strength and quiet resilience.
Hamida Begum's death leaves behind a family and a community that valued her contributions as both a teacher and a compassionate individual. Her Janaza took place in Nazira, where she had lived and worked for many years. She will be remembered by those who knew her for her gentle presence and commitment to education.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?